STOCK TITAN

Azenta, Inc. - $AZTA STOCK NEWS

Welcome to our dedicated page for Azenta news (Ticker: $AZTA), a resource for investors and traders seeking the latest updates and insights on Azenta stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Azenta's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Azenta's position in the market.

Rhea-AI Summary
Azenta, Inc. to host GENEWIZ Week featuring virtual workshops and grant program
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.22%
Tags
conferences
-
News
Rhea-AI Summary
Azenta announces new CFO and reaffirms guidance for Q4 fiscal 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
none
-
Rhea-AI Summary
Azenta, Inc. to present at Morgan Stanley Global Healthcare Conference on September 13, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Summary
Azenta, Inc. to present at Baird 2023 Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.89%
Tags
conferences
-
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) to participate in UBS MedTech, Tools and Genomics Summit 2023, with a live webcast accessible through their investor relations website. Replay available post-event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.57%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.57%
Tags
conferences
Rhea-AI Summary
Azenta, Inc. reported Q3 2023 financial results with revenue of $166 million, up 25% YoY and 12% sequentially. Diluted EPS from continuing operations was ($0.04), compared to ($0.09) in Q3 2022. The company generated positive free cash flow in the quarter. Guidance for Q4 2023 expects total revenue in the range of $155 to $173 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.33%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.59%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
none
Azenta, Inc.

Nasdaq:AZTA

AZTA Rankings

AZTA Stock Data

2.75B
49.84M
1.9%
105.44%
7.47%
Semiconductor and Related Device Manufacturing
Manufacturing
Link
United States of America
BURLINGTON

About AZTA

azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. azenta is headquartered in chelmsford, ma, with operations in north america, europe and asia. for more information, please visit www.azenta.com.